Literature DB >> 8706255

Formation of DNA adducts by the co-mutagen norharman with aromatic amines.

M Mori1, Y Totsuka, K Fukutome, T Yoshida, T Sugimura, K Wakabayashi.   

Abstract

Norharman, widely distributed in our environment, is alone not mutagenic to Salmonella typhimurium TA98 and TA100 either with or without S9 mix, but becomes mutagenic to S.typhimurium TA98 with S9 mix when non-mutagenic aromatic amines like aniline or o- or m-toluidine are added. Thus norharman has been called a 'co-mutagen'. In the present study we examined whether or not DNA adducts are formed in DNA of S.typhimurium TA98 by treatment with norharman and aromatic amines using 32P-post-labeling analysis under modified adduct intensification conditions. When a sample of norharman (8 mg) and aniline (4 mg) was incubated with 4 ml of overnight culture of S.typhimurium TA98 in the presence of 20 ml S9 mix for 6 h at 37 degrees C, three adduct spots were detected at a total relative adduct labeling (RAL) of 10.8 +/- 2.27/10(8) nucleotides. Under the same conditions, a mixture of norharman (8 mg) and o-toluidine (4 mg) yielded three adduct spots at a RAL of 3.74 +/- 1.71/10(8) nucleotides. With a combination of norharman and m-toluidine, a single adduct spot was seen at a RAL of 0.04 +/- 0.01/10(8) nucleotides. In contrast, norharman with p-toluidine did not produce adduct spots. Furthermore, neither norharman nor the aromatic amines themselves gave any evidence of adducts. Thus DNA adduct formation by norharman with aromatic amines correlates with the co-mutagenic action of norharman in S.typhimurium TA98.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8706255     DOI: 10.1093/carcin/17.7.1499

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  2 in total

1.  A new concept of co-mutagenicity from a phenomenon forgotten for the past two decades: is it more important than previously expected?

Authors:  T Sugimura
Journal:  Environ Health Perspect       Date:  1998-11       Impact factor: 9.031

2.  Crystal structure of 4-(4b,8a-di-hydro-9H-pyrido[3,4-b]indol-1-yl)-7-methyl-2H-chromen-2-one.

Authors:  S Samundeeswari; Manohar V Kulkarni; G N Anil Kumar
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2017-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.